Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2015 (2015), Article ID 595164, 5 pages
http://dx.doi.org/10.1155/2015/595164
Research Article

A Novel Mutation in the CYP11B1 Gene Causes Steroid 11β-Hydroxylase Deficient Congenital Adrenal Hyperplasia with Reversible Cardiomyopathy

1Department of Pediatrics, Aseer Central Hospital, Abha 62523, Saudi Arabia
2Department of Child Health, College of Medicine, King Khalid University, Abha 61421, Saudi Arabia
3Department of Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia

Received 11 May 2015; Revised 28 June 2015; Accepted 29 June 2015

Academic Editor: Franco Veglio

Copyright © 2015 Mohammad A. Alqahtani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. C. White, K. M. Curnow, and L. Pascoe, “Disorders of steroid 11β-hydroxylase isozymes,” Endocrine Reviews, vol. 15, no. 4, pp. 421–438, 1994. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Nimkarn and M. I. New, “Steroid 11β- hydroxylase deficiency congenital adrenal hyperplasia,” Trends in Endocrinology and Metabolism, vol. 19, no. 3, pp. 96–99, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. M. I. New, M. Abraham, B. Gonzalez et al., “Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 7, pp. 2611–2616, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Joehrer, S. Geley, E. M. C. Strasser-Wozak et al., “CYP11B1 mutations causing non-classic adrenal hyperplasia due to 11β-hydroxylase deficiency,” Human Molecular Genetics, vol. 6, no. 11, pp. 1829–1834, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Parajes, L. Loidi, N. Reisch et al., “Functional consequences of seven novel mutations in the CYP11B1 gene: four mutations associated with nonclassic and three mutations causing classic 11β-hydroxylase deficiency,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 2, pp. 779–788, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. P. W. Speiser and P. C. White, “Congenital adrenal hyperplasia,” The New England Journal of Medicine, vol. 349, no. 8, pp. 776–788, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Mornet, J. Dupont, A. Vitek, and P. C. White, “Characterization of two genes encoding human steroid 11β-hydroxylase (P-450(11β)),” The Journal of Biological Chemistry, vol. 264, no. 35, pp. 20961–20967, 1989. View at Google Scholar · View at Scopus
  8. I. Kuribayashi, S. Nomoto, G. Massa et al., “Steroid 11-beta-hydroxylase deficiency caused by compound heterozygosity for a novel mutation, p.G314R, in one CYP11B1 allele, and a chimeric CYP11B2/CYP11B1 in the other allele,” Hormone Research, vol. 63, no. 6, pp. 284–292, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Portrat, P. Mulatero, K. M. Curnow, J.-L. Chaussain, Y. Morel, and L. Pascoe, “Deletion hybrid genes, due to unequal crossing over between CYP11B1 (11beta-hydroxylase) and CYP11B2 (aldosterone synthase) cause steroid 11beta-hydroxylase deficiency and congenital adrenal hyperplasia,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 7, pp. 3197–3201, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Hampf, N. T. N. Dao, N. T. Hoan, and R. Bernhardt, “Unequal crossing-over between aldosterone synthase and 11β-hydroxylase genes causes congenital adrenal hyperplasia,” The Journal of Clinical Endocrinology & Metabolism, vol. 86, no. 9, pp. 4445–4452, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. O. Chabre, S. Portrat-Doyen, P. Chaffanjon et al., “Bilateral laparoscopic adrenalectomy for congenital adrenal hyperplasia with severe hypertension, resulting from two novel mutations in splice donor sites of CYP11B1,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 11, pp. 4060–4068, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. W. M. Hague and J. W. Honour, “Malignant hypertension in congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency,” Clinical Endocrinology, vol. 18, no. 5, pp. 505–510, 1983. View at Publisher · View at Google Scholar · View at Scopus
  13. A. S. Al Jarallah, “Reversible cardiomyopathy caused by an uncommon form of congenital adrenal hyperplasia,” Pediatric Cardiology, vol. 25, no. 6, pp. 675–676, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Bhatia, M. N. Muranjan, and K. R. Lahiri, “Left ventricular failure due to a rare variant of congenital adrenal hyperplasia,” Indian Journal of Pediatrics, vol. 79, no. 9, pp. 1241–1243, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. G. de Simone, A. P. Tommaselli, R. Rossi et al., “Partial deficiency of adrenal 11-hydroxylase. A possible cause of primary hypertension,” Hypertension, vol. 7, no. 2, pp. 204–210, 1985. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Richardson, R. W. McKenna, M. Bristow et al., “Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies,” Circulation, vol. 93, no. 5, pp. 841–842, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Arola, E. Jokinen, O. Ruuskanen et al., “Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland,” The American Journal of Epidemiology, vol. 146, no. 5, pp. 385–393, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. S. E. Lipshultz, L. A. Sleeper, J. A. Towbin et al., “The incidence of pediatric cardiomyopathy in two regions of the United States,” The New England Journal of Medicine, vol. 348, no. 17, pp. 1647–1655, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. A. W. Nugent, P. E. F. Daubeney, P. Chondros et al., “The epidemiology of childhood cardiomyopathy in Australia,” The New England Journal of Medicine, vol. 348, no. 17, pp. 1639–1646, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Kimura, “Molecular etiology and pathogenesis of hereditary cardiomyopathy,” Circulation Journal, vol. 72, supplement A, pp. A38–A48, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. Y.-F. Chang, J. S. Imam, and M. F. Wilkinson, “The nonsense-mediated decay RNA surveillance pathway,” Annual Review of Biochemistry, vol. 76, pp. 51–74, 2007. View at Publisher · View at Google Scholar · View at Scopus